HCV Populations
People Who Inject Drugs Should Have Access to Hepatitis C Treatment, Expert Panel Recommends
- Details
- Category: People Who Inject Drugs
- Published on Wednesday, 07 October 2015 00:00
- Written by Keith Alcorn
New recommendations on hepatitis C treatment and care encourage physicians to offer treatment to all people who inject drugs who are diagnosed with HCV infection, and to offer a comprehensive package of social support and harm reduction to enable people to adhere to treatment. The recommendations are published this month in the International Journal of Drug Policy, coinciding with the 4th International Symposium on Hepatitis Care in Substance Users taking place this week Sydney, which focuses on the management of hepatitis among drug users.
People on Opiate Substitution Therapy Respond Well to AbbVie Hepatitis C Treatment
- Details
- Category: People Who Inject Drugs
- Published on Thursday, 03 September 2015 00:00
- Written by Liz Highleyman
Nearly all genotype 1 hepatitis C patients with a history of injection drug use who were on stable opiate substitution therapy with methadone or buprenorphine were cured using AbbVie's Viekira Pak regimen plus ribavirin for 12 weeks, according to a Phase 2 study described in the August 2015Journal of Hepatology. No interactions were seen between opiate substitution therapy and the hepatitis C drugs.
Opioid Maintenance Therapy Linked to Lower Hepatitis C Rates for People Who Inject Drugs
- Details
- Category: People Who Inject Drugs
- Published on Tuesday, 28 October 2014 00:00
- Written by JAMA
Young drug injectors who undergo opioid agonist maintenance therapy using buprenorphine or methadone have a lower likelihood of becoming infected with hepatitis C virus (HCV) than those who continue injecting or use other types of substance use treatment, according to a study published in the October 27 edition of JAMA Internal Medicine.
AASLD 2014: Young Drug Injectors on Opioid Agonist Therapy Have Lower Risk of HCV Infection
- Details
- Category: People Who Inject Drugs
- Published on Monday, 10 November 2014 00:00
- Written by Liz Highleyman
Young people who inject drugs (PWID) who undergo opioid agonist maintenance therapy with methadone or buprenorphine have more than a 60% reduction in their risk of acquiring hepatitis C virus (HCV) over time, compared to those with no substance use treatment, according to a study presented Monday at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting in Boston. Findings were also published in the October 27 edition of JAMA Internal Medicine.
EACS 2013: HCV Reinfection Common Among HIV Positive Gay Men in Europe
- Details
- Category: Gay & Bisexual Men/MSM
- Published on Friday, 25 October 2013 00:00
- Written by Liz Highleyman
A study found that 18% of HIV positive men acquired hepatitis C virus (HCV) a second time after clearing the virus, with some having third and fourth infections as well, according to findings from the European AIDS Treatment Network presented at the 14th European AIDS Conference this month in Brussels.
Web Design and Development by